pRevTRE MKL1 Citations (2)
Originally described in: Serum-induced phosphorylation of the serum response factor coactivator MKL1 by the extracellular signal-regulated kinase 1/2 pathway inhibits its nuclear localization.Muehlich S, Wang R, Lee SM, Lewis TC, Dai C, Prywes R Mol Cell Biol. 2008 Oct;28(20):6302-13. doi: 10.1128/MCB.00427-08. Epub 2008 Aug 11. PubMed Journal
Articles Citing pRevTRE MKL1
| Articles |
|---|
| Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Tello-Lafoz M, Srpan K, Sanchez EE, Hu J, Remsik J, Romin Y, Calo A, Hoen D, Bhanot U, Morris L, Boire A, Hsu KC, Massague J, Huse M, Er EE. Immunity. 2021 May 11;54(5):1037-1054.e7. doi: 10.1016/j.immuni.2021.02.020. Epub 2021 Mar 22. PubMed |
| Multiplex imaging reveals novel patterns of MRTFA/B activation in the breast cancer microenvironment. Wilk SM, Lee K, Castillo CC, Haloul M, Gajda AM, Macias V, Wiley EL, Chen Z, Liu X, Wang X, Sverdlov M, Hoskins KF, Er EE. J Transl Med. 2025 May 30;23(1):599. doi: 10.1186/s12967-025-06559-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.